Without the benefit of examination and testing, coloplast is precluded from commenting on the condition of the device or the cause of the occurrence.Should additional facts prompt us to alter or supplement any information or conclusions contained in the original mdr or in any prior supplemental reports, a follow-up report will be submitted.
|
According to available information, a study was conducted that included this product type.The revision rates were 12% in the malleable group.The infection, edema and hematoma rates were 4.3% (15/349) in the malleable group.Of the complications and dissatisfaction, it was not specified how many involved this product type.
|